Premaitha Expands Capacity for Screening Service

News

Premaitha Expands Capacity for Screening Service

14 Oct, 2015

Published over 11 years ago. See the latest and most current information on News.

Due to a rise in demand for its non-invasive pregnancy screening service, Premaitha Health plc has opened a dedicated laboratory which will enable the company to dramatically increase throughput of the maternal blood samples analysed each month using the IONA® test. This in-vitro test estimates the risk of a foetus being affected by Down’s syndrome and other serious genetic conditions. The new Care Quality Commission (CQC)-accredited, clinical laboratory is based at Premaitha’s headquarters on Manchester Science Park.

Barry Hextall, CFO of Premaitha said: “The decision to expand our NIPT in-house service has been driven by demand from clinicians for the fast, accurate and accredited results provided by the IONA® test. These additional laboratory facilities and our extended team of specialists who run the IONA® test service means we can offer the benefits of the first and only CE-marked in-vitro diagnostic product for NIPT to more pregnant women, sooner.  This also fulfils one of the commercialisation objectives stated at the time of the recent fundraising.”

Latest News

LMUK 51.7 Nov 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Phenol on the ground: what a COMAH prosecution shows about soil data as evidence
Explore more Arrow
Pollution Solutions Online
Pump and mixer service at paper mill set to reach 40 years
Explore more Arrow
Petro Online
Hydrogen sulphide deaths expose the gaps in gas detection during non-routine work
Explore more Arrow
Chromatography Today
High-load peptide purification
Explore more Arrow